116 related articles for article (PubMed ID: 35950469)
21. Alcohol dependence potentiates substance P/neurokinin-1 receptor signaling in the rat central nucleus of amygdala.
Khom S; Steinkellner T; Hnasko TS; Roberto M
Sci Adv; 2020 Mar; 6(12):eaaz1050. PubMed ID: 32206720
[TBL] [Abstract][Full Text] [Related]
22. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation.
Lai JP; Ho WZ; Kilpatrick LE; Wang X; Tuluc F; Korchak HM; Douglas SD
Proc Natl Acad Sci U S A; 2006 May; 103(20):7771-6. PubMed ID: 16675550
[TBL] [Abstract][Full Text] [Related]
23. Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated mice.
Glaser S; Gaudio E; Renzi A; Mancinelli R; Ueno Y; Venter J; White M; Kopriva S; Chiasson V; DeMorrow S; Francis H; Meng F; Marzioni M; Franchitto A; Alvaro D; Supowit S; DiPette DJ; Onori P; Alpini G
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G297-305. PubMed ID: 21596993
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer.
Zahiri E; Ghorbani H; Moradi A; Mehrad-Majd H; Mohammadi F; Sharifi Sistani N; Hashemy SI
Rep Biochem Mol Biol; 2022 Oct; 11(3):411-420. PubMed ID: 36718293
[TBL] [Abstract][Full Text] [Related]
25. Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study.
Amoruso A; Bardelli C; Cattaneo CI; Fresu LG; Manzetti E; Brunelleschi S
J Affect Disord; 2015 Jun; 178():188-92. PubMed ID: 25841180
[TBL] [Abstract][Full Text] [Related]
26. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells.
Li X; Ma G; Ma Q; Li W; Liu J; Han L; Duan W; Xu Q; Liu H; Wang Z; Sun Q; Wang F; Wu E
Mol Cancer Res; 2013 Mar; 11(3):294-302. PubMed ID: 23345604
[TBL] [Abstract][Full Text] [Related]
27. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
28. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
Vigna SR
Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
[TBL] [Abstract][Full Text] [Related]
29. Substance P and the neurokinin-1 receptor regulate electroencephalogram non-rapid eye movement sleep slow-wave activity locally.
Zielinski MR; Karpova SA; Yang X; Gerashchenko D
Neuroscience; 2015 Jan; 284():260-272. PubMed ID: 25301750
[TBL] [Abstract][Full Text] [Related]
30. Substance P receptor expression in human skin keratinocytes and fibroblasts.
Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
[TBL] [Abstract][Full Text] [Related]
31. Analysis on correlation between SP and NK-1R and intranasal mucosal contact point headache.
Zhao G; Yin J; Peng H; Wang J
Acta Otolaryngol; 2016; 136(5):522-7. PubMed ID: 26817501
[TBL] [Abstract][Full Text] [Related]
32. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
[TBL] [Abstract][Full Text] [Related]
33. Substance P Promotes the Progression of Endometrial Adenocarcinoma.
Ma J; Yuan S; Cheng J; Kang S; Zhao W; Zhang J
Int J Gynecol Cancer; 2016 Jun; 26(5):845-50. PubMed ID: 27051050
[TBL] [Abstract][Full Text] [Related]
34. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
Remröd C; Lonne-Rahm S; Nordlind K
Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
[TBL] [Abstract][Full Text] [Related]
35. Neurokinin-1 receptor antagonism improves postoperative neurocognitive disorder in mice.
Li Z; Luo T; Ning X; Xiong C; Wu A
Neurosci Lett; 2018 Nov; 687():189-195. PubMed ID: 30273701
[TBL] [Abstract][Full Text] [Related]
36. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
[TBL] [Abstract][Full Text] [Related]
37. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
[TBL] [Abstract][Full Text] [Related]
38. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP.
Bremer AA; Leeman SE; Boyd ND
J Biol Chem; 2001 Jun; 276(25):22857-61. PubMed ID: 11294866
[TBL] [Abstract][Full Text] [Related]
39. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
[TBL] [Abstract][Full Text] [Related]
40. Difference in expression of two neurokinin-1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma.
Gao X; Wang Z
Oncol Lett; 2017 Sep; 14(3):3729-3733. PubMed ID: 28927139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
